The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount ...

The AHA Aug. 27 said the Health Resources and Services Administration should abandon its 340B Rebate Model Pilot Program.

The 340B Drug Pricing Program is a vital lifeline for rural hospitals, but it needs responsible reform to preserve its original intent.

New York hospitals that participate in 340B should be required to publicly report how much revenue they generate from the ...

Just days and weeks away from key deadlines, the hospital industry’s leading trade organization is still calling for the administration to scrap a one-year pilot of drugmakers’ preferred approach t | ...

The 340B program is not a prescription drug benefit for uninsured or low-income patients. Rather, it allows covered entities enrolled in the program to purchase drugs at the 340B discounted price ...

The 340B program is an existing program that allows certain eligible hospitals and other providers to purchase outpatient drugs at a discount from pharmaceutical manufacturers.

Federal lawmakers have proposed legislation that targets core healthcare issues, including 340B, Medicaid, AI and ...

The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a ...

The 340B program includes about 40 percent of all U.S. hospitals and an even larger number of clinics — tens of thousands of them depend on these reduced drug prices.